The 20th edition of BioAsia – The Marquee Healthcare and Life Sciences event, organized by the Government of Telangana, has announced that the coveted Genome Valley Excellence Award for the year 2023 will be conferred upon Prof. Robert S. Langer, in light of his pioneering research that has led to the development of the first commercial mRNA vaccines used for a variety of infectious diseases. Langer is currently the David H. Koch Institute Professor at Massachusetts Institute of Technology (MIT), USA. He is also being acknowledged for his exemplary research in human health, including the detection, monitoring, and treatment of cancer. A veteran in his field, his remarkable contributions to biomedical and therapeutic research include developing long-term and controlled-release drug delivery systems used for a variety of applications including cancer therapy, insulin, and vaccines.
Related Posts
Mismatched, Superstar’s Hidden Wife to Bandish Bandits; Unconventional Love Stories on OTT That Steal the Spotlight
Gone are the days of conventional love narratives that reduce protagonists to mere puzzle pieces, incomplete without their counterpart. The…
Gunnebo Safe Storage Expands Presence in North Karnataka with New Display Centre in Hubli
Hubli, Feb 09: Gunnebo, a global leader in physical security solutions, has further strengthened its footprint in South India with the…
Echoes of Kashmir: The Wazwan Feast at Rosetta Sakleshpur
Saffron, spices, and centuries of culinary mastery converge on a grand copper platter for Wazwan, the legendary royal feast of…